Open Outbreak

Rift Valley fever

Also known as: RVF, Rift Valley fever virus

Rift Valley fever (RVF) is a viral disease that primarily affects livestock but can also infect humans. It is transmitted through contact with infected animal blood or organs, or through bites from infected mosquitoes. Symptoms in humans range from mild flu-like illness to severe complications such as hemorrhagic fever. The disease is endemic in parts of Africa and the Arabian Peninsula, with outbreaks often linked to heavy rainfall and flooding. There is no specific treatment, but supportive care can help manage symptoms. Vaccines exist for animals, but human vaccines are not widely available.

Key facts

TransmissionContact with infected animal blood or organs, bites from infected mosquitoes.
Incubation2 to 6 days.
Case fatalityVaries; up to 50% in severe cases.
Reproduction numberunknown
VaccineAvailable for animals; limited availability for humans.
TreatmentSupportive care; no specific antiviral treatment.
ReservoirPrimarily livestock (e.g., cattle, sheep, goats, camels).
Endemic regionsSub-Saharan Africa, Arabian Peninsula.

Transmission

Rift Valley fever (RVF) is primarily transmitted to humans through direct contact with the blood, organs, or other bodily fluids of infected animals, such as during slaughtering or veterinary procedures. It can also be transmitted through the bites of infected mosquitoes, which act as vectors for the virus. Consuming unpasteurized or undercooked milk from infected animals is another potential route of transmission. Human-to-human transmission has not been documented.

Symptoms and severity

In humans, RVF can cause a range of symptoms. Most cases are mild, presenting as flu-like symptoms such as fever, muscle pain, and headaches. However, in some cases, the disease can progress to more severe forms, including hemorrhagic fever, encephalitis, or ocular disease, which can lead to blindness. The case fatality rate can be as high as 50% in severe cases.

Treatment and vaccines

There is no specific antiviral treatment for RVF. Management of the disease in humans is primarily supportive, focusing on alleviating symptoms and preventing complications. Vaccines are available for animals to prevent outbreaks, but human vaccines are not widely available and are generally used in high-risk populations or research settings.

Where it occurs

RVF is endemic in sub-Saharan Africa and the Arabian Peninsula. Outbreaks are often associated with periods of heavy rainfall and flooding, which create favorable conditions for mosquito breeding. Countries such as Mauritania, Senegal, Kenya, and Sudan have reported recurrent outbreaks.

Recent history

Since 1996, there have been 21 documented outbreaks of RVF, with notable events in Mauritania, Senegal, Kenya, and Sudan. The most recent outbreak occurred between September and October 2025 in Mauritania and Senegal, with 404 confirmed human cases and 42 deaths reported. This outbreak was associated with heavy rains and increased mosquito activity, highlighting the environmental factors that contribute to the spread of the disease.

What to watch

Key factors to monitor include environmental conditions such as heavy rainfall and flooding, which can lead to increased mosquito populations and higher risk of RVF outbreaks. Monitoring livestock health and implementing vaccination programs in endemic regions are crucial. Additionally, surveillance for human cases, especially among high-risk groups like farmers and veterinarians, is essential to prevent and control outbreaks.

Updated